{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:20:38Z","timestamp":1784024438079,"version":"3.55.0"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,7,23]]},"published-print":{"date-parts":[[2024,10]]},"DOI":"10.2967\/jnumed.124.267775","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T17:00:39Z","timestamp":1726160439000},"page":"1526-1532","source":"Crossref","is-referenced-by-count":11,"title":["Development of<sup>18<\/sup>F-Fluoromisonidazole Hypoxia PET\/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance"],"prefix":"10.2967","volume":"65","author":[{"given":"Rick","family":"Wray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mauguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Leithner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosna","family":"Mirtcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Humm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"2024100105350765000_65.10.1526.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00101-6"},{"key":"2024100105350765000_65.10.1526.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227744"},{"key":"2024100105350765000_65.10.1526.3","doi-asserted-by":"crossref","unstructured":"Wegge M Dok R Nuyts S . Hypoxia and its influence on radiotherapy response of HPV-positive and HPV-negative head and neck cancer. Cancers (Basel). 2021;13:5959.","DOI":"10.3390\/cancers13235959"},{"key":"2024100105350765000_65.10.1526.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.2878"},{"key":"2024100105350765000_65.10.1526.5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2020.05.022","article-title":"Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy","volume":"149","author":"Zschaeck","year":"2020","journal-title":"Radiother Oncol."},{"key":"2024100105350765000_65.10.1526.6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/hed.24445","article-title":"Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1\u03b1","volume":"38","author":"Swartz","year":"2016","journal-title":"Head Neck."},{"key":"2024100105350765000_65.10.1526.7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1773"},{"key":"2024100105350765000_65.10.1526.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2005.06.038"},{"key":"2024100105350765000_65.10.1526.9","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90146-6"},{"key":"2024100105350765000_65.10.1526.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.10.049"},{"key":"2024100105350765000_65.10.1526.11","doi-asserted-by":"crossref","unstructured":"Elming PB Sorensen BS Oei AL . Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia. Cancers (Basel). 2019;11:60.","DOI":"10.3390\/cancers11010060"},{"key":"2024100105350765000_65.10.1526.12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13014-017-0914-9","article-title":"Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas","volume":"12","author":"Glowa","year":"2017","journal-title":"Radiat Oncol."},{"key":"2024100105350765000_65.10.1526.13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00259-015-3247-7","article-title":"Quantitative and qualitative analysis of [18F]FDG and [18F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome","volume":"43","author":"Graves","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024100105350765000_65.10.1526.14","doi-asserted-by":"crossref","first-page":"e64730","DOI":"10.1371\/journal.pone.0064730","article-title":"Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation","volume":"8","author":"Wulbrand","year":"2013","journal-title":"PLoS One."},{"key":"2024100105350765000_65.10.1526.15","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3109\/0284186X.2014.990109","article-title":"Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study","volume":"54","author":"Servagi-Vernat","year":"2015","journal-title":"Acta Oncol."},{"key":"2024100105350765000_65.10.1526.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.06.039"},{"key":"2024100105350765000_65.10.1526.17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2022.03.021","article-title":"Dose escalation to hypoxic subvolumes in head and neck cancer: a randomized phase II study using dynamic [18F]FMISO PET\/CT","volume":"171","author":"Welz","year":"2022","journal-title":"Radiother Oncol."},{"key":"2024100105350765000_65.10.1526.18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2016.04.027","article-title":"Strategy of using intratreatment hypoxia imaging to selectively and safely guide radiation dose de-escalation concurrent with chemotherapy for locoregionally advanced human papillomavirus-related oropharyngeal carcinoma","volume":"96","author":"Lee","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2024100105350765000_65.10.1526.19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djaa184","article-title":"Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial","volume":"113","author":"Riaz","year":"2021","journal-title":"J Natl Cancer Inst."},{"key":"2024100105350765000_65.10.1526.20","doi-asserted-by":"crossref","unstructured":"Lee NY Sherman EJ Sch\u00f6der H . Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma. J Clin Oncol. 2024;42:940\u2013950.","DOI":"10.1200\/JCO.2024.42.16_suppl.6007"},{"key":"2024100105350765000_65.10.1526.21","unstructured":"Gamer M Fellows I Singh P . Package \u2018irr.\u2019 The Comprehensive R Archive Network website. https:\/\/cran.r-project.org\/web\/packages\/irr\/irr.pdf. Published October 13, 2022. Accessed August 13, 2024."},{"key":"2024100105350765000_65.10.1526.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2024100105350765000_65.10.1526.23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the Prostate Cancer Molecular Imaging Standardized Evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"key":"2024100105350765000_65.10.1526.24","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)91001-4"},{"key":"2024100105350765000_65.10.1526.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.109330"},{"key":"2024100105350765000_65.10.1526.26","unstructured":"Giardiello D Quatto P Ripamonti E Vigliani S . Package \u2018raters.\u2019 The Comprehensive R Archive Network website. https:\/\/cran.r-project.org\/web\/packages\/raters\/raters.pdf. Published July 18, 2024. Accessed August 13, 2024."},{"key":"2024100105350765000_65.10.1526.27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0688-3"},{"key":"2024100105350765000_65.10.1526.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-1096-7"},{"key":"2024100105350765000_65.10.1526.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2015.09.015"},{"key":"2024100105350765000_65.10.1526.30","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/hed.24925","article-title":"18F-fluoromisonidazole positron emission tomography\/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: a feasibility study","volume":"39","author":"Qiu","year":"2017","journal-title":"Head Neck."},{"key":"2024100105350765000_65.10.1526.31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"key":"2024100105350765000_65.10.1526.32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.20.00386","article-title":"Standardization of 18F-FDG-PET\/CT according to Deauville criteria for metabolic complete response definition in newly diagnosed multiple myeloma","volume":"39","author":"Zamagni","year":"2021","journal-title":"J Clin Oncol."},{"key":"2024100105350765000_65.10.1526.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.11.061"},{"key":"2024100105350765000_65.10.1526.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"2024100105350765000_65.10.1526.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264106"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.267775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T12:37:13Z","timestamp":1727786233000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.267775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,1]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.2967\/jnumed.124.267775"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.267775","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}